GL1X · GenesisL1 explorer

MolNFT v1 · #95750 · protein

The E41Q mutant of the amidase from nesterenkonia sp. AN1 showing the result of michael addition of acrylamide at the active site cysteine

4IZU: “The E41Q mutant of the amidase from nesterenkonia sp. AN1 showing the result of michael addition of…”. X-ray diffraction, 2 ligands (ROP, 1HC), 1 pocket (best druggability 0.37). MolNFT v1 #95750 on GenesisL1: 3D structure, binding…

PDB
4IZU
Type
protein
Length
254 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Amidase
EC
3.5.1.4
UniProt
D0VWZ1
Ligands
ROP, 1HC
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAmidase (EC 3.5.1.4)protein25435% helix, 28% strandD0VWZ1

Ligands and binding sites

  • ROP · Propionamide · ligand · 2 copies · chains A
  • 1HC · prop-2-enamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.370.7919ROP

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4IZU · The E41Q mutant of the amidase from Nesterenkonia sp. AN1 showing the result of Michael… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.